Diabetes and cardiorenal syndrome: Understanding the “Triple Threat”

Objective: Diabetes is known to be associated with chronic kidney disease (CKD) and cardiovascular disease (CVD) independently. Type 2 cardiorenal syndrome (CRS), a recently defined syndrome, is characterized by primary renal failure that progressively leads to cardiac dysfunction. The effect of dia...

Full description

Bibliographic Details
Main Authors: Srikanta Banerjee, Raymond Panas
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:Hellenic Journal of Cardiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1109966616302482
id doaj-c500098afd5c4d01ac4664a7d4ac599d
record_format Article
spelling doaj-c500098afd5c4d01ac4664a7d4ac599d2020-11-24T23:37:15ZengElsevierHellenic Journal of Cardiology1109-96662017-09-0158534234710.1016/j.hjc.2017.01.003Diabetes and cardiorenal syndrome: Understanding the “Triple Threat”Srikanta Banerjee0Raymond Panas1Johns Hopkins School of Public Health, United StatesWalden University School of Health Sciences, United StatesObjective: Diabetes is known to be associated with chronic kidney disease (CKD) and cardiovascular disease (CVD) independently. Type 2 cardiorenal syndrome (CRS), a recently defined syndrome, is characterized by primary renal failure that progressively leads to cardiac dysfunction. The effect of diabetes on cardiorenal syndrome has not been explored in a multi-ethnic population. In this retrospective secondary analysis, the hypothesis that diabetes modifies the effect of CVD on CKD was tested. Methods: The National Health and Nutrition Examination Survey (NHANES) is a cross-sectional survey that was performed on the non-institutionalized population in the United States. All patients from the NHANES study, who were 20 years and older between the years 1999 and 2010, were included in the analysis. CKD was determined using the Cockcroft-Gault equation. The analysis was performed using a complex samples logistic regression to determine the relationship between diabetes and CRS. Results: The prevalence of CKD among the population was 9.6% in Non-Hispanic Whites, 8.9% in African-Americans, and 4.5% in Hispanics. The overall unadjusted odds ratio for CKD to no CKD was 6.89 (95% confidence interval [CI], 6.13–7.75, p < 0.001). The adjusted OR was elevated, 2.25 (CI 1.56–3.23, p < 0.001), among individuals with diabetes but was approximately 1.0 (1.43 CI 1.16–1.76, p < 0.05) among patients without diabetes after controlling for medical risk factors and demographic risk factors. Conclusion: Diabetes is strongly associated with Type 2 CRS in a nationally representative multi-ethnic population and must be considered when treating patients. Longitudinal studies should further examine this association.http://www.sciencedirect.com/science/article/pii/S1109966616302482Cardiovascular DiseaseChronic Kidney DiseaseCardiorenal SyndromeDiabetesNHANES
collection DOAJ
language English
format Article
sources DOAJ
author Srikanta Banerjee
Raymond Panas
spellingShingle Srikanta Banerjee
Raymond Panas
Diabetes and cardiorenal syndrome: Understanding the “Triple Threat”
Hellenic Journal of Cardiology
Cardiovascular Disease
Chronic Kidney Disease
Cardiorenal Syndrome
Diabetes
NHANES
author_facet Srikanta Banerjee
Raymond Panas
author_sort Srikanta Banerjee
title Diabetes and cardiorenal syndrome: Understanding the “Triple Threat”
title_short Diabetes and cardiorenal syndrome: Understanding the “Triple Threat”
title_full Diabetes and cardiorenal syndrome: Understanding the “Triple Threat”
title_fullStr Diabetes and cardiorenal syndrome: Understanding the “Triple Threat”
title_full_unstemmed Diabetes and cardiorenal syndrome: Understanding the “Triple Threat”
title_sort diabetes and cardiorenal syndrome: understanding the “triple threat”
publisher Elsevier
series Hellenic Journal of Cardiology
issn 1109-9666
publishDate 2017-09-01
description Objective: Diabetes is known to be associated with chronic kidney disease (CKD) and cardiovascular disease (CVD) independently. Type 2 cardiorenal syndrome (CRS), a recently defined syndrome, is characterized by primary renal failure that progressively leads to cardiac dysfunction. The effect of diabetes on cardiorenal syndrome has not been explored in a multi-ethnic population. In this retrospective secondary analysis, the hypothesis that diabetes modifies the effect of CVD on CKD was tested. Methods: The National Health and Nutrition Examination Survey (NHANES) is a cross-sectional survey that was performed on the non-institutionalized population in the United States. All patients from the NHANES study, who were 20 years and older between the years 1999 and 2010, were included in the analysis. CKD was determined using the Cockcroft-Gault equation. The analysis was performed using a complex samples logistic regression to determine the relationship between diabetes and CRS. Results: The prevalence of CKD among the population was 9.6% in Non-Hispanic Whites, 8.9% in African-Americans, and 4.5% in Hispanics. The overall unadjusted odds ratio for CKD to no CKD was 6.89 (95% confidence interval [CI], 6.13–7.75, p < 0.001). The adjusted OR was elevated, 2.25 (CI 1.56–3.23, p < 0.001), among individuals with diabetes but was approximately 1.0 (1.43 CI 1.16–1.76, p < 0.05) among patients without diabetes after controlling for medical risk factors and demographic risk factors. Conclusion: Diabetes is strongly associated with Type 2 CRS in a nationally representative multi-ethnic population and must be considered when treating patients. Longitudinal studies should further examine this association.
topic Cardiovascular Disease
Chronic Kidney Disease
Cardiorenal Syndrome
Diabetes
NHANES
url http://www.sciencedirect.com/science/article/pii/S1109966616302482
work_keys_str_mv AT srikantabanerjee diabetesandcardiorenalsyndromeunderstandingthetriplethreat
AT raymondpanas diabetesandcardiorenalsyndromeunderstandingthetriplethreat
_version_ 1725520783424356352